Cardiovascular Pharmacology

Citations 501-510 of 640 total displayed.

Past content (since Jan 1999):

Scientific Contributions
Phorbol Diacetate Potentiates Na⁺-K⁺ ATPase Inhibition by a Putative Endogenous Ligand, Marinobufagenin

Olga V. Fedorova, Natalia A. Dorofeeva, Denis A. Lopatin, Edward G. Lakatta, and Alexei Y. Bagrov
Hypertension 2002;39:298-302, doi:10.1161/hy0202.104344 [Abstract] [Full text]  

Scientific Contributions
Effect of ACE Inhibitors and Angiotensin II Type 1 Receptor Antagonists on Endothelial NO Synthase Knockout Mice With Heart Failure

Yun-He Liu, Jiang Xu, Xiao-Ping Yang, Fang Yang, Edward Shesely, and Oscar A. Carretero
Hypertension 2002;39:375-381, doi:10.1161/hy02t2.102796 [Abstract] [Full text]  

Scientific Contributions
Methoxyestradiols Mediate the Antimitogenic Effects of Locally Applied Estradiol on Cardiac Fibroblast Growth

Raghvendra K. Dubey, Delbert G. Gillespie, Lefteris C. Zacharia, Marinella Rosselli, Bruno Imthurn, and Edwin K. Jackson
Hypertension 2002;39:412-417, doi:10.1161/hy0202.102837 [Abstract] [Full text]  

Scientific Contributions
Prorenin-Induced Myocyte Proliferation: No Role for Intracellular Angiotensin II

Jasper J. Saris, Mark M.E.D. van den Eijnden, Jos M.J. Lamers, Pramod R. Saxena, Maarten A.D.H. Schalekamp, and A.H. Jan Danser
Hypertension 2002;39:573-577, doi:10.1161/hy0202.103002 [Abstract] [Full text]  

Scientific Contributions
Perindopril Alters Vascular Angiotensin-Converting Enzyme, AT₁ Receptor, and Nitric Oxide Synthase Expression in Patients With Coronary Heart Disease

Jia Long Zhuo, Frederick A.O. Mendelsohn, and Mitsuru Ohishi
Hypertension 2002;39:634-638, doi:10.1161/hy0202.103417 [Abstract] [Full text]  

Scientific Contributions
Functional Significance of Activation of Calcium/Calmodulin–Dependent Protein Kinase II in Angiotensin II–Induced Vascular Hyperplasia and Hypertension

Mubarack M. Muthalif, Nour A. Karzoun, Ibrahim F. Benter, Lillian Gaber, Farid Ljuca, Mohammed R. Uddin, Zinat Khandekar, Anne Estes, and Kafait U. Malik
Hypertension 2002;39:704-709, doi:10.1161/hy0202.103823 [Abstract] [Full text]  

Hypertension Electronic Pages
Angiotensin II Suppression in Humans by the Orally Active Renin Inhibitor Aliskiren (SPP100): Comparison With Enalapril

Juerg Nussberger, Grégoire Wuerzner, Chris Jensen, and Hans R. Brunner
Hypertension 2002;39: -8e, doi:10.1161/hy0102.102293 [Abstract] [Full text]  

Scientific Contributions
Insulin Inhibits Acetylcholine Responses in Rat Isolated Mesenteric Arteries via a Non-Nitric Oxide Nonprostanoid Pathway

Masahiko Kimura, Ann-Maree Jefferis, Hiroshi Watanabe, and Jaye Chin-Dusting
Hypertension 2002;39:35-40, doi:10.1161/hy1201.097198 [Abstract] [Full text]  

Scientific Contributions
L-Arginine Augments Cardiac Vagal Control in Healthy Human Subjects

Saqib Chowdhary, Sarah L. Nuttall, John H. Coote, and Jonathan N. Townend
Hypertension 2002;39:51-56, doi:10.1161/hy0102.098308 [Abstract] [Full text]  

Scientific Contributions
Combined Endopeptidase Inhibition and Adrenomedullin in Sheep With Experimental Heart Failure

Miriam T. Rademaker, Chris J. Charles, Garth J.S. Cooper, David H. Coy, Eric A. Espiner, Lynley K. Lewis, M. Gary Nicholls, and A. Mark Richards
Hypertension 2002;39:93-98, doi:10.1161/hy0102.099197 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64